Dr. Carroll appointed to lead cancer center strategic planning at UCSF
Peter R. Carroll, MD, has been appointed director of clinical services and strategic planning of the University of California, San Francisco Comprehensive Cancer Center and associate dean of the UCSF School of Medicine.
Peter R. Carroll, MD, has been appointed director of clinical services and strategic planning of the University of California, San Francisco Comprehensive Cancer Center and associate dean of the UCSF School of Medicine. In his new position, Dr. Carroll will focus on expanding existing clinical programs and will establish a clinical delivery system able to support and execute translational research.
Dr. Carroll has been a member of the UCSF faculty since 1986 and has served as the chair of the department of urology since 1996. He has also been surgeon-in-chief at the UCSF Comprehensive Cancer Center since 2003. He is an international expert on the diagnosis and management of urologic malignancies.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
Experts develop guide on online tools to reduce costs of urologic drugs
April 22nd 2024"At a time when patients are increasingly concerned about prescription drugs, this information will provide a useful starting point for making essential medications as affordable as possible," says Ruchika Talwar, MD.
